Novo Nordisk (NVO) stock crashed Friday after the pharmaceutical giant’s next-generation weight-loss drug missed expectations in a highly anticipated study. Shares of rivals Eli Lilly (LLY) and Vikin… [+4184 chars]Read More
Novo Crashes 20 After New Obesity Drug Misses Forecasts Lilly Viking Amgen Jump Investors Business Daily
